126 related articles for article (PubMed ID: 16142871)
1. Association of nuclear factor-kappaB in psoriatic arthritis.
Butt C; Sun S; Peddle L; Greenwood C; Hamilton S; Gladman D; Rahman P
J Rheumatol; 2005 Sep; 32(9):1742-4. PubMed ID: 16142871
[TBL] [Abstract][Full Text] [Related]
2. Association of SEEK1 and psoriatic arthritis in two distinct Canadian populations.
Rahman P; Butt C; Siannis F; Farewell VT; Peddle L; Pellett FJ; Schentag C; Gladman DD
Ann Rheum Dis; 2005 Sep; 64(9):1370-2. PubMed ID: 15708881
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
Kim TH; Stone MA; Rahman P; Yoo DH; Park YW; Payne U; Hallett D; Inman RD
J Rheumatol; 2005 Oct; 32(10):1907-10. PubMed ID: 16206345
[TBL] [Abstract][Full Text] [Related]
4. Association of interleukin 23 receptor variants with psoriatic arthritis.
Rahman P; Inman RD; Maksymowych WP; Reeve JP; Peddle L; Gladman DD
J Rheumatol; 2009 Jan; 36(1):137-40. PubMed ID: 19040306
[TBL] [Abstract][Full Text] [Related]
5. Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris.
Li H; Gao L; Shen Z; Li CY; Li K; Li M; Lv YJ; Li CX; Gao TW; Liu YF
Arch Dermatol Res; 2008 Sep; 300(8):425-33. PubMed ID: 18330586
[TBL] [Abstract][Full Text] [Related]
6. PPAR-gamma gene polymorphisms and psoriatic arthritis.
Butt C; Gladman D; Rahman P
J Rheumatol; 2006 Aug; 33(8):1631-3. PubMed ID: 16783862
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 polymorphisms in patients with ankylosing spondylitis in Korea.
Kim TJ; Kim TH; Lee HJ; Peddle L; Rahman P; Hu P; Greenwood CM; Inman RD
J Rheumatol; 2008 Aug; 35(8):1603-8. PubMed ID: 18484691
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
[TBL] [Abstract][Full Text] [Related]
10. A functional polymorphism of the NFKB1 gene increases the risk for alcoholic liver cirrhosis in patients with alcohol dependence.
Marcos M; Pastor I; González-Sarmiento R; Laso FJ
Alcohol Clin Exp Res; 2009 Nov; 33(11):1857-62. PubMed ID: 19673747
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients.
Lo SS; Chen JH; Wu CW; Lui WY
Surgery; 2009 Mar; 145(3):280-5. PubMed ID: 19231580
[TBL] [Abstract][Full Text] [Related]
12. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.
Karban AS; Okazaki T; Panhuysen CI; Gallegos T; Potter JJ; Bailey-Wilson JE; Silverberg MS; Duerr RH; Cho JH; Gregersen PK; Wu Y; Achkar JP; Dassopoulos T; Mezey E; Bayless TM; Nouvet FJ; Brant SR
Hum Mol Genet; 2004 Jan; 13(1):35-45. PubMed ID: 14613970
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study.
Assmann G; Pfoehler C; Simon P; Pfreundschuh M; Tilgen W; Wieczorek S
J Dermatol; 2011 Jun; 38(6):519-23. PubMed ID: 21352301
[TBL] [Abstract][Full Text] [Related]
14. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
Riemann K; Becker L; Struwe H; Nückel H; Dührsen U; Alakus H; Winde G; Neuhäuser M; Rübben H; Schmitz KJ; Wohlschlaeger J; Schmid KW; Siffert W
Pharmacogenet Genomics; 2006 Nov; 16(11):783-8. PubMed ID: 17047486
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis.
Ravindran JS; Owen P; Lagan A; Lewis J; Korendowych E; Welsh K; McHugh N
Rheumatology (Oxford); 2004 Jan; 43(1):22-6. PubMed ID: 12890860
[TBL] [Abstract][Full Text] [Related]
16. TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele.
Reich K; Hüffmeier U; König IR; Lascorz J; Lohmann J; Wendler J; Traupe H; Mössner R; Reis A; Burkhardt H
Arthritis Rheum; 2007 Jun; 56(6):2056-64. PubMed ID: 17530646
[TBL] [Abstract][Full Text] [Related]
17. IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients.
Eder L; Chandran V; Pellett F; Pollock R; Shanmugarajah S; Rosen CF; Rahman P; Gladman DD
Ann Rheum Dis; 2011 Sep; 70(9):1594-8. PubMed ID: 21613309
[TBL] [Abstract][Full Text] [Related]
18. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease.
Rueda B; Núñez C; López-Nevot MA; Paz Ruiz M; Urcelay E; De la Concha EG; Martín J
Scand J Gastroenterol; 2006 Apr; 41(4):420-3. PubMed ID: 16635909
[TBL] [Abstract][Full Text] [Related]
19. The functional role of nuclear factor kappa-kappaB1 -94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory study.
Yalcin B; Atakan N; Alli N
Clin Exp Dermatol; 2008 Aug; 33(5):629-33. PubMed ID: 18616724
[TBL] [Abstract][Full Text] [Related]
20. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
